$3.7 million grant to fund research on novel drug targeting heart diseases

(Louisiana State University Health Sciences Center) The Exscien Corporation of Louisville, Ky., in conjunction with LSU Health New Orleans Cardiovascular Center of Excellence, has been awarded an SBIR Fast-Track grant in the amount of $3.7 million over three years by the National Heart, Lung and Blood Institute. The funding will be used to study the company's first in a new class of drugs that repairs DNA damage to reduce cardiac tissue injury and improve outcomes in cardiovascular diseases.